Key players across the healthcare industry—including sponsors, contract research organizations (CROs), research sites, regulators and patient advocates—are well aware of the challenges associated with ...
CT screening for lung cancer could save countless lives, but low participation rates have led to some eyebrow-raising proposals. Molecular methods, touted by those with a vested interest, promise to ...
Researchers are to trial a ground-breaking screening test for pre-eclampsia, a potentially life-threatening condition affecting pregnant women and their unborn babies. The Screen and Treat with ...
Breast and colorectal cancer screening rates in 2023 surpassed pre-pandemic levels with increases of 7% and 12%, respectively, while cervical cancer screening remained 14% below 2019 levels.